The clinical data analysis with TCGA database showed that higher Sec23a and Atg5 expression levels appear to be protective factors and favorable diagnostic (TNM staging) and prognostic (overall survival) markers for SKCM and COAD patients, though they are not independent markers (data not shown). The gene discussed is SEC23A; the disease is colon adenocarcinoma.